Clonal identification and homology differentiate primary central nervous system lymphoma from non-central nervous system lymphoplasmacytic lymphoma: a case report

It was revealed that the lymphoma cells of both lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and primary central nervous system lymphoma derived from a common cell possessing MYD88. The utility of adding chemotherapy for low-grade lymphoma in addition to therapy for primary central nervous system lymphoma is not clear. While lymphoplasmacytic lymphoma is a low-grade lymphoma that does not always require chemotherapy, combining treatment for lymphoplasmacytic lymphoma and primary central nervous system lymphoma may contribute to the effectiveness of both treatments.

Authors

Institutions

Publication Details

Journal
Journal of Medical Case Reports
Published
2025-11-21
DOI
https://doi.org/10.1186/s13256-025-05677-2
Primary Topic
CNS Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clonal identification and homology differentiate primary central nervous system lymphoma from non-central nervous system lymphoplasmacytic lymphoma: a case report

Daigo Akahane, Tamiko Suguro, Nahoko Furuya, Seiichi Okabe et al.
Journal of Medical Case Reports
CNS Lymphoma Diagnosis and Treatment
article

Clonal identification and homology differentiate primary central nervous system lymphoma from non-central nervous system lymphoplasmacytic lymphoma: a case report

Daigo Akahane, Tamiko Suguro, Nahoko Furuya, Seiichi Okabe, Seiichiro Katagiri, Shinjiro Fukami, Toshitaka Nagao, Moritaka Gotoh, Yuko Tanaka, Mitsuru Moriyama, Hiroaki Fujimoto, Akihiko Gotoh, Naoya Nakamura, Maki Tanigawa, Michiyo Asano, Akiko Yamada, Michihiro Kohno, S Ohtsuki, Jun Matubayashi, Seiichiro Yosizawa
article en

Abstract

It was revealed that the lymphoma cells of both lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and primary central nervous system lymphoma derived from a common cell possessing MYD88. The utility of adding chemotherapy for low-grade lymphoma in addition to therapy for primary central nervous system lymphoma is not clear. While lymphoplasmacytic lymphoma is a low-grade lymphoma that does not always require chemotherapy, combining treatment for lymphoplasmacytic lymphoma and primary central nervous system lymphoma may contribute to the effectiveness of both treatments.

Journal of Medical Case ReportsVol. 19(1)
Tokai University (JP), Tokyo Medical University (JP)
Openalex Percentile: Top 51%
CNS Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clonal identification and homology differentiate primary central nervous system lymphoma from non-central nervous system lymphoplasmacytic lymphoma: a case report — Daigo Akahane, Tamiko Suguro, et al. · Journal of Medical Case Reports (2025) | TGRS Research Map | TGRS